Search

everythinglearnresearchcommunity

for

Search:↓

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

Bimekizumab effectively treated a man's chronic beard hair loss.

Semaglutide is an effective weekly treatment for obesity, promoting weight loss and improving health, despite some side effects.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Some IBD patients on anti-TNFs developed severe skin issues, but ustekinumab helped.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Upadacitinib improved multiple immune-related conditions in one patient.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Upadacitinib effectively treats psoriasis and lichen planus together.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

A patient's grey hair regained color during treatment with adalimumab.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

A patient got a skin reaction on their hands and feet after using secukinumab for psoriasis.

A woman developed psoriasis after taking certolizumab pegol, improving after stopping the drug and starting other treatments.

Tildrakizumab significantly improved psoriasis symptoms and well-being over 52 weeks.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

The new delivery system could improve pain and inflammation relief in gout.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

An elderly man's hair grew back after treatment with secukinumab, possibly due to reduced scalp inflammation or the medication's direct effects.

Canakinumab's effect on COVID-19 outcomes is unclear.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

Ustekinumab and vedolizumab can help some ulcerative colitis patients with hair regrowth, but results vary.